Target audience

The course is primarily aimed at academic researchers having a basic knowledge of virology and vaccinology with more interactive learning materials provided for the early phases of vaccine development during which academia is more involved. However, as it provides a complete overview it will be helpful for anyone wishing to gain an overview of veterinary vaccine development.

Requirements and qualifications

Access to a computer with a reliable internet connection is essential. The course is prepared in English (UK).

Course details

  • 6-7-hour course
  • £200 ex VAT       
  • Internet required 
  • Self-directed
  • Email us

Learning outcomes

Divided into six individual modules, you will be able to:

  • Understand what a Target Product Profile is and how it facilitates vaccine development.
  • Know key questions that should be addressed during the Discovery and Feasibility phase including important technology transfer considerations.
  • Discuss the challenges faced when transferring technologies from academia to industry.
  • Explain the key elements of early- and late-stage veterinary vaccine development.
  • Describe the complexity of product licensing and registration.

Course modules

The course comprises of the following modules:

  • INTRODUCTION
    • Introduction
    • Learning Objectives
  • TARGET PRODUCT PROFILE
    • Target Product Profile
  • VACCINE RESEARCH
    • Discovery & Feasibility
  • VACCINE DEVELOPMENT
    • Early-Phase Development
    • Late-Phase Development
  • PRODUCT LICENCING AND REGULATIONS
    • Product Licencing and Regulations
  • THE PIRBRIGHT INSTITUTE
    • Vaccine Success Stories
  • SUMMARY
    • Summary
    • Glossary of Terms
    • Acknowledgements

 

Next steps

Contact Pirbright Training for portal access details.

 

“It was very helpful and informative.”

Discover more